Quotes 5-day view Delayed London Stock Exchange
08/04/2022
08/05/2022
08/08/2022
08/09/2022
08/10/2022
Date
1658.4(c)
1667(c)
1659.4(c)
1646.8(c)
1556.6
Last
4 413 895
3 917 789
3 254 908
5 624 487
12 919 214
Volume
-1.10%
+0.52%
-0.46%
-0.76%
-5.48%
Change
Estimated financial data (e) GBP USD
Sales 2022
29 863 M
36 095 M
36 095 M
Net income 2022
4 410 M
5 330 M
5 330 M
Net Debt 2022
15 314 M
18 510 M
18 510 M
P/E ratio 2022
15,2x
Yield 2022
3,48%
Sales 2023
30 498 M
36 863 M
36 863 M
Net income 2023
5 020 M
6 067 M
6 067 M
Net Debt 2023
12 012 M
14 519 M
14 519 M
P/E ratio 2023
13,2x
Yield 2023
3,47%
Capitalization
66 668 M
80 582 M
80 582 M
EV / Sales 2022
2,75x
EV / Sales 2023
2,58x
Nbr of Employees
90 096
Free-Float
93,6%
GSK plc, formerly GlaxoSmithKline PLC is a global healthcare company. The Company is focused to improve the quality of human life by helping people. The Company operates through three core businesses: Pharmaceuticals, Vaccines and Consumer Healthcare. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency viruses (HIV), immuno-inflammation and oncology. It also...
News in other languages on GSK PLC
Analyst Recommendations on GSK PLC
Analysis-As inflation soars, European consumer goods M&A slows
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends GSK PLC
Short Term Mid-Term Long Term Trends Bearish Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
1 646,80 GBX
Average target price
2 038,46 GBX
Spread / Average Target
23,8%
Please enable JavaScript in your browser's settings to use dynamic charts.
1st jan. Capi. (M$)
GSK PLC 0.20% 80 582